Skip Navigation

This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boffetta, P.
Right arrow Articles by Brennan, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boffetta, P.
Right arrow Articles by Brennan, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 12, 2139, December 2002
© 2002 Oxford University Press


RESPONSE TO LETTER TO THE EDITOR

Proper controls for SNP studies?

Paolo Boffetta and Paul Brennan

Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, 150 cours Albert-Thomas, 69008 Lyon, France

Email: boffetta{at}iarc.fr, brennan{at}iarc.fr

Dear Sir,

We agree with Hemminki and Försti that, for association studies aimed at establishing whether an SNP modifies the risk of a disease, the use of a convenient, large control group may be justified, as long as the genotype distribution follows the Hardy–Weinberg equilibrium. Deciding whether confounding by ethnicity may be present, however, is not trivial when (i) the underlying population is ethnically heterogeneous; (ii) no individual information is available on the ethnic distribution of the control group; and (iii) participation in the control group might be associated with ethnicity (e.g. via social class). As in all observational research, in SNP studies there are no all-purpose solutions, rather compromises between resources, availability of subjects and samples, and approaches to control biases. Therefore, we plea for a careful consideration of issues pertaining to the study design, including the choice of control groups and the size of the study populations, no matter which is the purpose of the study.

Received August 18, 2002; accepted August 18, 2002.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
B. Frank, K. Hemminki, B. Wappenschmidt, A. Meindl, R. Klaes, R. K. Schmutzler, P. Bugert, M. Untch, C. R. Bartram, and B. Burwinkel
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant
Carcinogenesis, March 1, 2006; 27(3): 606 - 609.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boffetta, P.
Right arrow Articles by Brennan, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boffetta, P.
Right arrow Articles by Brennan, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?